India’s drug regulator CDSCO on Thursday reposnded to the World Health Organisation (WHO) that three cough syrups — Coldrif, RespifreshTR and ReLife — have been recalled and manufacturers have been ordered to stop their production. The CDSCO has also informed the global health agency that none of the products were exported from India.






